Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
1191252-49-9
2R)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-5-amino-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S
a proteolytic cascade regulating hemodynamics and water and electrolyte balance
3)14(20)13(19-10-17-9-18-19)8-11-4-6-12(16)7-5-11/h4-7
InChi: InChI=1S/C9H7NO2/c11-8-3-1-2-7-6(8)4-5-10-9(7)12/h1-5
Famitinib Size:Contact [email protected] for quotation 1191252-49-9Famitinib (SHR1020), an orally active multi targeted kinase inhibitor, inhibits the activity of c kit, VEGFR 2 and PDGFR with IC50 values of 2. 3 nM, 4. 7 nM and 6. 6 nM, respectively. Famitinib exerts powerful antitumor activity in human gastric cancer cells and xenografts. Famitinib triggers apoptosis. Famitinib is a novel multi targeted receptor tyrosine kinase inhibitor under development for cancer treatment. Famitinib is a structural analogue of
US$ 1012.50
US$ 404.50
US$ 3096.72
US$ 567.50
US$ 32.00
US$ 10.50
US$ 138.99
US$ 179.99
US$ 115.00
US$ 37.20
US$ 322.50
US$ 16.80